Stanford University — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Dispatch Bio develops a universal immunotherapy treatment for solid tumors, combining engineered immunotherapy with a tumor-specific virus to improve cancer treatment outcomes.
BiotechDeep TechMedical Devices
Lex Johnson(Co-Founder and Chief Platform Officer)inRay Liu(Co-founder and Head of Synthetic Biology)Jeff Marrazzo(Founder)inSabah Oney(Chief Executive Officer)in
Co-investorsARCH Venture PartnersAlexandria
Maritime Fusion designs and builds zero-emission fusion reactors for deployment in maritime transport and remote energy installations.
Advanced ManufacturingCleantechDeep TechEnergySan Francisco, US
Justin Cohen(Founder)inJason Kaufmann(Founder)in
Co-investorsAera VCAlumni VenturesAvant LabsTrucks VCY CombinatorBatch Ventures+4 more
Upscale AI builds networking infrastructure purpose-built for AI workloads, including scale-up rack networking (SkyHammer) and open Ethernet fabrics based on NVIDIA Spectrum-X silicon and a SONiC-based network OS.
AI & Machine LearningCloud ComputingData & InfrastructureDeep TechHardwareSemiconductorsSanta Clara, US
Rajiv K.(Founder)inBarun Kar(CEO)inRajiv Khemani(Executive Chairman)
Co-investorsBreakpoint CapitalCelesta CapitalCloudbreak Ventures Kft.Cota CapitalIntel CapitalMayfield Fund+12 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

















